Other NIH components contributing support to the initiatives are the National Institute of Neurological Disorders and Stroke (resuscitation consortium), and the National Institute for Biomedical Imaging and Bioengineering (cellular and molecular imaging). NIH is part of the U.S. Department of Health and Human Services.

Together, NHLBI and ICRH have launched three requests for grant applications:

• "Clinical Research Consortium to Improve Resuscitation Outcomes" will establish a consortium of several regional centers in which investigators, emergency medical personnel, and community leaders work cooperatively to translate promising research into effective strategies to resuscitate patients who experience heart attacks or life-threatening trauma outside of the hospital. The deadline for applications is November 13, 2003; letters of intent must be received by October 16, 2003. (http://www.nhlbi.nih.gov/funding/inits/resus_faq.htm)

• "Cellular and molecular imaging of the cardiovascular, pulmonary, and hematopoietic system" will support the development of new cellular and molecular imaging technologies specific to cardiovascular, pulmonary, and blood systems, which could ultimately contribute to new non-invasive diagnostic tests and novel therapeutic approaches, including cell-based therapies for diseases related to these systems. Grant applications are due January 22, 2004, with letters of intent due December 22, 2003. (http://grants1.nih.gov/grants/guide/rfa-files/RFA-HL-04-003.html)

• "Inflammation and Thrombosis," will support research to study the relationship of inflammation and thrombosis (eg, clotting) in blood vessels and to discover ways that would improve curr
  '"/>